Identification of a sequence likely to be required for avian retroviral packaging.
Two assays have been utilized to assess the ability of avian retroviral molecules to be packaged into virus particles. Cloned viral genomic molecules were microinjected into the nuclei of chick cells infected by either a lymphoid leukosis virus or an envelope glycoprotein-deficient sarcoma virus. The titer of focus-forming virus released by injected cells, or the ratio of these to helper virus, is then used to determine packaging efficiency, although biological properties other than packaging might also effect these assays. With either assay, deletions up to 3.0 kbp introduced in the viral gag or pol genes did not affect packaging unless sequences near the SstII restriction site (approximately 150 bp 3' of the splice donor site) were deleted. Deletions differing by 2 bp at the SstII site were found to express radically different packaging efficiencies.
D000818:Animals; D001354:Avian Leukosis Virus / Q000235:genetics* / Q000378:metabolism; D001358:Avian Sarcoma Viruses / Q000235:genetics* / Q000378:metabolism; D001483:Base Sequence; D002460:Cell Line; D002642:Chick Embryo; D004262:DNA Restriction Enzymes; D004279:DNA, Viral / Q000378:metabolism; D005814:Genes, Viral; D008845:Microinjections; D012326:RNA Splicing; D012367:RNA, Viral / Q000378:metabolism*
D004279:DNA, Viral; D012367:RNA, Viral; D004262:DNA Restriction Enzymes